Persistent Asset Partners’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$392K Sell
2025
Q1
$502K Buy
2024
Q4
$489K Buy